Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Project Inform perspective

Showing results (21-30 of 280) with videos related to

Pageof 28
Sort By:
Project Inform Perspective|May 22, 2001
The power of words
Project Inform Perspective|May 22, 2001
Simpler regimens for preventing mother-to-child HIV transmission
Project Inform Perspective|May 22, 2001
Work Incentives Improvement Act
Project Inform Perspective|July 1, 1997
HIV drug side effects
Project Inform Perspective|July 1, 1997
HIV neuropathy
Project Inform Perspective|July 1, 1997
Thalidomide study
Project Inform Perspective|May 22, 2001
Salvage therapy studies
Project Inform Perspective|May 22, 2001
Geno- and phenotypic resistance tests
Project Inform Perspective|May 22, 2001
Efavirenz (Sustiva) receives FDA approval. Food and Drug Administration
Project Inform Perspective|May 22, 2001
Medicaid expansion update
Pageof 28

Showing results (21-30 of 280) with videos related to

Sort By:
Pageof 28
Project Inform Perspective|May 22, 2001
The power of words
Project Inform Perspective|May 22, 2001
Simpler regimens for preventing mother-to-child HIV transmission
Project Inform Perspective|May 22, 2001
Work Incentives Improvement Act
Project Inform Perspective|July 1, 1997
HIV drug side effects
Project Inform Perspective|July 1, 1997
HIV neuropathy
Project Inform Perspective|July 1, 1997
Thalidomide study
Project Inform Perspective|May 22, 2001
Salvage therapy studies
Project Inform Perspective|May 22, 2001
Geno- and phenotypic resistance tests
Project Inform Perspective|May 22, 2001
Efavirenz (Sustiva) receives FDA approval. Food and Drug Administration
Project Inform Perspective|May 22, 2001
Medicaid expansion update
Pageof 28